WORLD
Patient Selection for AstraZeneca, Daiichi Breast Cancer Drug Needs Improvement, Experts ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say ...'
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say https://t.co/N7yMsCxC6q pic.twitter.com/G1C8dp6m34— Reuters (@Reuters) December 9, 2022
(The above story first appeared on LatestLY on Dec 09, 2022 11:29 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
